Physician profile
Lois Mailander
NPI 1851375281
$2,080.24
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $198 · 2021: $464 · 2022: $168 · 2023: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $412.96 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $331.75 | 2019-2022 | |
| Pfizer INC. | $266.50 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $154.72 | 2019-2022 | |
| Amgen INC. | $139.66 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $109.57 | 2019-2021 | |
| Amarin Pharma, INC. | $105.04 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $90.54 | 2021-2023 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $73.17 | 2019-2021 | |
| Esperion Therapeutics, INC. | $65.88 | 2021-2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.37 | 2021-2023 | |
| Baxter Healthcare | $49.25 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.34 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $39.80 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.98 | 2022-2023 | Verquvo |
| Atricure, INC. | $20.98 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.96 | 2019 | |
| Gilead Sciences, INC. | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lois Mailander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.